NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 47 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $9,000 | -83.6% | 65,484 | -72.8% | 0.00% | -87.5% |
| Q3 2018 | $55,000 | +89.7% | 240,400 | +14.6% | 0.01% | +33.3% |
| Q2 2018 | $29,000 | -64.6% | 209,802 | -30.9% | 0.01% | -70.0% |
| Q1 2018 | $82,000 | -56.8% | 303,503 | -40.1% | 0.02% | -56.5% |
| Q4 2017 | $190,000 | -37.1% | 506,634 | -26.4% | 0.05% | -41.8% |
| Q3 2017 | $302,000 | -49.1% | 688,471 | -54.3% | 0.08% | -53.0% |
| Q2 2017 | $593,000 | -16.9% | 1,507,457 | -2.9% | 0.17% | -20.4% |
| Q1 2017 | $714,000 | +7.0% | 1,551,874 | -1.7% | 0.21% | -5.4% |
| Q4 2016 | $667,000 | – | 1,578,519 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Platinum Management (NY) LLC | 10,375,329 | $13,549,000 | 19.76% |
| Catalyst Capital Advisors LLC | 790,000 | $1,635,000 | 0.53% |
| DSC Advisors, L.P. | 500,000 | $1,035,000 | 0.50% |
| STONERIDGE INVESTMENT PARTNERS LLC | 142,528 | $295,000 | 0.06% |
| Hudock, Inc. | 30,500 | $63,000 | 0.05% |
| BRR OpCo, LLC | 52,700 | $109,000 | 0.05% |
| TFS CAPITAL LLC | 418,074 | $865,000 | 0.04% |
| LifePlan Financial Group, Inc | 28,810 | $60,000 | 0.04% |
| NOMURA HOLDINGS INC | 3,831,177 | $7,947,000 | 0.04% |
| BOLTON LP | 77,400 | $160,000 | 0.03% |